MRI characteristics of patients with natalizumab-associated PML and histologically confirmed IRIS. Axial FLAIR images (a, c, e) of MS patients, cases 1, 2, and 3, with corresponding contrast-enhanced T1-weighted images (b, d, f) are shown. Different patterns of enhancement in IRIS can be seen, ranging from faint peripheral enhancement to intense enhancement of the lesions (open arrows in b, d, and f). The area of biopsy is indicated (closed arrows in a, c, and e)